AKT1 and epilepsy: From literature it is evident that inhibiting AKT1 prevents epilepsy in a rat model of temporal lobe epilepsy67, it therefore seems rational that modulating AKT signalling through Ibudilast treatment could reduce seizures in FXS patients.